Pathogenetic bases and efficacy of slow calcium channel blockers in the therapy of recurrent peptic ulcer disease associated with hypertension

Fomina L.A.; Chernin V.V.

doi:https://doi.org/10.17116/terarkh201789210-14

Fomina L.A.

Tverskaia gosudarstvennaia meditsinskaia akademiia Minzdrava RF

Chernin V.V.

Tverskaia gosudarstvennaia meditsinskaia akademiia Minzdrava RF

Pathogenetic bases and efficacy of slow calcium channel blockers in the therapy of recurrent peptic ulcer disease associated with hypertension

Authors:

Fomina L.A., Chernin V.V.

More about the authors

Journal: Therapeutic Archive. 2017;89(2): 10‑14

DOI: 10.17116/terarkh201789210-14

Read: 3207 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Fomina LA, Chernin VV. Pathogenetic bases and efficacy of slow calcium channel blockers in the therapy of recurrent peptic ulcer disease associated with hypertension. Therapeutic Archive. 2017;89(2):10‑14. (In Russ.)
https://doi.org/10.17116/terarkh201789210-14

Использование инфографики авторами научных работ

Close metadata

Abstract:

Aim. To clarify blood calcium concentrations (BCCs) as an indicator of the functional state of the calcium-regulating system in the concomitant course of recurrent peptic ulcer disease (PUD) and hypertension, by comparing with the severity of a ulcerous process, with changes in regional microcirculation, and with the functions of the stomach. To elucidate the pathogenetic justification for and clinical efficacy of slow calcium channel blockers (SCCBs) in the treatment of this comorbidity. Subjects and methods. In the case-control study, each patient with recurrent PUD and grade 1, Stage I hypertension (Group 1; n=23) corresponded to a recurrent PUD patient matched for sex, age, and ulcer site (Group 2, n=23). The complex of treatment for these patients included the SCCB nifedipine. A control group consisted of 56 recurrent PUD patients who received combination therapy without nifedipine. All the patients over time underwent clinical and endoscopic examinations and determinations of BCCs, indicators of gastric secretory and motor functions, and regional microcirculation in the gastroduodenal mucosal biopsy specimens. Results. Recurrent PUD was present with a reliable BCC increase that was more substantial when it was associated with hypertension. Calcium imbalance was accompanied by changes in regional microcirculation and gastric secretory and motor functional indicators forming an acid peptic factor, as well as by hypermotor dyskinesia, which were more pronounced in patients with comorbidity. Incorporation of a SCCB into a complex of therapy for recurrent PUD to eliminate the pathogenic effect of blood calcium contributed to more rapid arrest of the clinical symptoms of a recurrence, to elimination of acute-phase microcirculatory disorders in the gastroduodenal zone, and to the recovery of gastric functional indicators. Elevated blood pressure was ruled out during the therapy of concomitant diseases. Conclusion. Incorporation of a SCCB into the combination therapy of recurrent PUD associated with hypertension is pathogenetically sound and clinically effective.

Keywords:

peptic ulcer disease

hypertension

calcium

microcirculation

gastric function

slow calcium channel blocker

Authors:

Fomina L.A.

Tverskaia gosudarstvennaia meditsinskaia akademiia Minzdrava RF

Chernin V.V.

Tverskaia gosudarstvennaia meditsinskaia akademiia Minzdrava RF

Close metadata

References:

Krylov A. To the problem of the compatibility of disease. Klinicheskaya meditsina. 2000;1:56-68. (In Russ.).
Van den Akker M, Buntinx F, Metsemakers JF et all Multimorbidity in general practice: prevalence, incidence and determinants of co-occurring chronic and recurrent diseases. J. Clin. Epidemiol. 2008;51(5):367-375.
Uspenskii Yu. The Problem of combined pathology in the clinic of gastroenterology. Gastroenterologiya Sankt-Peterburga. 2005;3-4:33-36. (In Russ.).
Khlynova O, Tuev A. Hypertension and acid-related diseases Perm': Poligrafkomplekt. 2008. (In Russ.).
Zvenigorodskaya L, Lazebnik L, Tarachenko Yu. Clinical and diagnostic features of diseases of the digestive system pathology of the cardiovascular system. Eksperimental'naya i klinicheskaya gastroenterologiya. 2005;5:139-140. (In Russ.).
Lazebnik L, Drozdov V. Diseases of the digestive system in the elderly. Anakharsis; 2003. (In Russ.).
Lazebnik L, Komisarenko I, Milyukova O. Hypertension in the elderly. M.: Izd-vo MAI; 2002. (In Russ.).
Chernin V. Diseases of the esophagus, stomach and duodenum. M.: «MIA»; 2010:528. (In Russ.).
Mikheeva O. Peptic ulcer disease in elderly patients with arterial hypertension. Klinicheskaya gerontologiya. 2008;1:17-29. (In Russ.).
Chernin V, Fomina L. Сalciumregulating system and recurrence of peptic ulcer disease. Terapevticheskii arkhiv. 2016;88(2):10-15. (In Russ.).
Fomina L. the Calcium-phosphorus balance in the recurrence of peptic ulcer disease. Eksperimental'naya i klinicheskaya gastroenterologiya. 2011;12:22-26. (In Russ.).
Temaeva I, Balushkina S, Efimov N. Evaluation of imbalance of chemical elements in patients with arterial hypertension. Kazanskii meditsinskii zhurnal. 2016;97(4):501-507. (In Russ.).
Kelegama E. peculiarities of separate parts of calcium homeostasis depending on the severity of arterial hypertension. Krymskii terapevticheskii zhurnal. 2007;1(8):22-25. (In Russ.).
Balabina N, Baglushkina S. Element status and risk of development of cardiovascular complications in hypertensive patients. Sibirskii meditsinskii zhurnal (Irkutsk). 2014;125(2):51.85. (In Russ.).
Kolesnikova L, Dolgikh V, Prokhorov J, Grebenkina L, Vlasov B, Ilyin V. Features of the system «lipid Peroxidation, antioxidant protection» and of calcium metabolism in adolescents with essential arterial hypertension. Pediatriya. Zhurnal im. G.N. Speranskogo. 2010;89(3):10-14. (In Russ.).
Yankovskaya L, Śnieżnik V, Lyalikov A. Calcium and phosphorus metabolism in women with arterial hypertension. Kardiologiya v Belarusi. 2013;5(30):74-85. (In Russ.).
Logina T, Iskenderov B, Shibaeva T, Berenstein N Ermolaeva N, Kireeva M. the Effectiveness of calcium antagonists depending on the content of parathyroid hormone in the blood in patients with arterial hypertension. Kardiovaskulyarnaya terapiya i profilaktika. 2008;7(6 S1):219a-220. (In Russ.).
Chernin V, Fomina L. Pathogenetic basis for the use of calcium antagonists in the treatment of relapse of peptic ulcer. Eksperimental'naya i klinicheskaya gastroenterologiya. 2003;4:41-48. (In Russ.).
Martsevich S. the Treatment of hypertension digidropiridinovmi calcium antagonists in the form of monotherapy in combination with beta blockers. Rossiiskii kardiologicheskii zhurnal. 2002;3:4-12. (In Russ.).
Makolkin V. Calcium antagonists — drugs of choice in the treatment of arterial hypertension. Rossiiskii meditsinskii zhurnal. 2007;22:1599. (In Russ.).